Porton Pharma Solutions Ltd. (SHE:300363)

Porton Pharma Solutions Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 7, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	9,407	8,602	13,735	22,305	48,697	19,821
Market Cap Growth	-2.37%	-37.37%	-38.42%	-54.20%	145.68%	155.21%
Enterprise Value	10,117	9,403	13,249	20,598	48,168	18,944
Last Close Price	17.35	15.77	24.34	38.24	83.52	34.02
PE Ratio	-	-	51.47	11.12	92.95	61.10
Forward PE	208.21	54.14	27.07	12.63	71.85	51.44
PS Ratio	3.00	2.86	3.75	3.17	15.68	9.57
PB Ratio	1.74	1.59	2.25	3.45	11.63	5.84
P/TBV Ratio	2.02	1.85	2.62	4.13	13.64	6.48
P/FCF Ratio	-	-	-	16.03	-	179.53
P/OCF Ratio	22.97	21.21	21.83	8.70	101.42	39.30
PEG Ratio	-	0.76	0.76	0.76	0.76	0.76
EV/Sales Ratio	3.23	3.12	3.61	2.93	15.51	9.14
EV/EBITDA Ratio	31.85	98.05	22.82	8.40	66.91	38.06
EV/EBIT Ratio	-	-	45.39	9.29	86.65	51.66
EV/FCF Ratio	-992.76	-	-	14.81	-	171.59
Debt / Equity Ratio	0.36	0.36	0.32	0.14	0.18	0.07
Debt / EBITDA Ratio	6.17	11.40	3.08	0.37	0.99	0.50
Debt / FCF Ratio	-	-	-	0.66	-	2.28
Asset Turnover	-	0.33	0.38	0.84	0.56	0.49
Inventory Turnover	-	3.10	2.76	4.10	3.11	3.20
Quick Ratio	1.48	1.37	1.94	1.47	1.12	1.72
Current Ratio	2.05	1.90	2.63	1.81	1.52	2.22
Return on Equity (ROE)	-4.64%	-6.36%	2.79%	36.34%	12.55%	10.01%
Return on Assets (ROA)	-	-1.54%	1.87%	16.59%	6.28%	5.42%
Return on Capital (ROIC)	-0.69%	-1.81%	2.36%	22.50%	8.11%	6.50%
Return on Capital Employed (ROCE)	-	-	3.70%	31.10%	12.50%	10.40%
Earnings Yield	-2.10%	-3.35%	1.94%	8.99%	1.08%	1.64%
FCF Yield	-0.11%	-0.99%	-3.65%	6.24%	-0.61%	0.56%
Dividend Yield	2.83%	-	2.00%	2.89%	0.23%	0.36%
Payout Ratio	-	-	234.79%	6.44%	15.80%	25.44%
Buyback Yield / Dilution	6.90%	0.31%	-0.21%	-0.62%	0.11%	-1.99%
Total Shareholder Return	9.74%	0.31%	1.79%	2.27%	0.34%	-1.63%

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.